Learn more →
Back to Expert Scholars
research / researchcancer immunology

Eicke Latz

艾克·拉茨

MD, PhD

🏢University of Bonn / Institute of Innate Immunity(波恩大学/先天免疫研究所)🌐Germany

Director, Institute of Innate Immunity; Professor of Immunology先天免疫研究所所长,免疫学教授

94
h-index
2
Key Papers
4
Awards
3
Key Contributions

👥Biography 个人简介

Eicke Latz is a world authority on the NLRP3 inflammasome and innate immune sensing mechanisms. His laboratory at the University of Bonn has made landmark contributions to understanding how the NLRP3 inflammasome is activated by danger signals in the tumor microenvironment, producing IL-1β and IL-18 that shape anti-tumor immunity. His work on pyroptosis and gasdermin D pore formation has revealed new mechanisms of immunogenic cancer cell death.

Share:

🧪Research Fields 研究领域

NLRP3 InflammasomeNLRP3炎症小体
Pyroptosis焦亡
IL-1β SignalingIL-1β信号
Gasdermin DGasdermin D
Innate Immune Activation in Tumors肿瘤中的先天免疫激活

🎓Key Contributions 主要贡献

NLRP3 Activation Mechanisms

Elucidated the two-signal model of NLRP3 activation and defined potassium efflux as the universal proximal trigger, providing mechanistic understanding relevant to tumor-induced inflammation.

Pyroptosis in Anti-Tumor Immunity

Showed that gasdermin D-mediated pyroptosis of tumor cells releases DAMPs that activate dendritic cells and promote anti-tumor CD8+ T cell responses.

Inflammasome-Targeted Therapy

Developed selective NLRP3 inhibitors (MCC950 analogs) and defined contexts where inflammasome blockade can reduce tumor-promoting chronic inflammation while sparing anti-tumor immunity.

Representative Works 代表性著作

[1]

Activation and regulation of the inflammasomes

Nature Reviews Immunology (2013)

Comprehensive review of NLRP3 inflammasome biology cited over 3,000 times, defining the mechanistic framework for innate immune sensing in cancer and sterile inflammation.

[2]

Gasdermin D pore formation mediates immunogenic tumor cell death and activates dendritic cells

Nature Immunology (2021)

Demonstrated that GSDMD-mediated pyroptosis releases HMGB1 and ATP from tumor cells, activating DNGR-1+ cDC1s to cross-prime anti-tumor CD8+ T cells.

🏆Awards & Recognition 奖项与荣誉

🏆German Research Foundation (DFG) Leibniz Prize
🏆ERC Advanced Grant
🏆Boehringer Ingelheim Prize in Medical Science
🏆EMBO Member

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 艾克·拉茨 的研究动态

Follow Eicke Latz's research updates

留下邮箱,当我们发布与 Eicke Latz(University of Bonn / Institute of Innate Immunity)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment